Parkinson's News Today Home | Parkinson's News Today
WEB5 days ago · Want to stay up to date on all the latest on Parkinson’s disease? Click the link below to find more news and information.
Brain molecule reverses movement deficits of Parkinson's, …
WEB1 day ago · Brain molecule reverses movement deficits of Parkinson's, offering new therapeutic target. A research team from the University of California, Irvine is the first to reveal that a molecule in the ...
New Parkinson’s drug could slow or reverse progression of …
WEBAug 21, 2024 · New Parkinson’s drug could slow or reverse progression of disease, researchers say: ‘Big step forward’. Published On. August 21, 2024. Social Media. Share this article. “People with Parkinson’s should be aware that although the findings were interesting, this was only a safety, tolerability and immunogenicity study, and thus there is ...
New Study Further Personalizes Deep Brain Stimulation | Parkinson…
WEB3 days ago · Oct 03, 2024. Deep brain stimulation (DBS) is a surgical treatment that provides relief to people with Parkinson's disease (PD) who experience movement symptoms and medication side effects. Since its U.S. Food and Drug Administration (FDA) approval to treat PD symptoms in 2002, DBS can help reduce medication needs and stabilize symptoms.
A Potential Parkinson’s Treatment Has Promising Results
WEBJun 20, 2024 · A small new trial published in the journal Nature Medicine describes what would be two firsts for Parkinson's disease, if they pan out: a diagnostic test and a potential immune-based treatment...
Breakthrough Parkinson’s Treatment Enters Human Trials
WEBAug 7, 2024 · A clinical trial has begun to offer a new treatment to people with Parkinson’s disease, following a study by University of Wisconsin–Madison scientists. This study, conducted on non-human primates, confirmed that the therapeutic delivery method is …
New Parkinson’s Treatments in the Clinical Trial Pipeline for 2024
WEBSep 26, 2023 · Extensive research is underway to develop new medications for Parkinson's disease (PD), with several promising candidates at different stages of development.
Parkinson's vaccine seen to target toxic protein in Phase 1 trial
WEBMar 11, 2024 · Treatment with UB-312, a vaccine designed to trigger an immune response against toxic clumps of the alpha-synuclein protein, reduced these damaging aggregations in people with Parkinson’s disease in a Phase 1 trial.
New Vaccine for Parkinson’s Moves Closer to 1st Human Trials
WEBDec 1, 2022 · An experimental vaccine that stimulates immune responses against three regions of the alpha-synuclein protein — whose toxic clumps contribute to Parkinson’s disease and dementia with Lewy bodies (DLB) — is moving into late-stage preclinical research aimed at supporting future requests to test it in clinical trials.
New therapeutic target for Parkinson’s disease discovered
WEBJul 19, 2023 · Northwestern Medicine scientists have uncovered a new mechanism by which mutations in a gene parkin contribute to familial forms of Parkinson's disease. The discovery opens a new avenue for Parkinson’s therapeutics, scientists report in …